Compared to other types of NSCLC, ROS1-positive NSCLC has a significantly increased risk of developing thromboembolic diseases (Shah et al., 2021; Woodford et al., 2021; Zhu et al., 2021), but the underlying mechanism remains unclear. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.